Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
The Journal of Biological Chemistry|January 25, 1980
Subunit composition, organic anion binding, catalytic and immunological properties of ligandin from rat testisM M Bhargava, N Ohmi, I Listowsky, et al.
Oncology|January 1, 1982
Hepatocellular ligandin during N-2-fluorenylacetamide carcinogenesisM M Bhargava, N Ohmi, I M Arias, et al.
The Journal of Antimicrobial Chemotherapy|August 6, 2002
Localization of [14C]clarithromycin in rat gastric tissue when administered with lansoprazole and amoxicillinH Endo, H Yoshida, N Ohmi, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 27, 2004
S-oxidation of S-methyl-esonarimod by flavin-containing monooxygenases in human liver microsomesN Ohmi, H Yoshida, H Endo, et al.
The Journal of Clinical Investigation|August 1, 1983
Hepatic bilirubin uptake in the isolated perfused rat liver is not facilitated by albumin bindingY R Stollman, U Gärtner, L Theilmann, et al.
Biochemical and Biophysical Research Communications|May 31, 1991
Antibody against neurofibromatosis type 1 gene product reacts with a triton-insoluble GTPase activating protein toward ras p21S Hattori, N Ohmi, M Maekawa, et al.
The Journal of Biological Chemistry|October 5, 1988
Affinity labeling of ras oncogene product p21 with guanosine diphospho- and triphosphopyridoxalsN Ohmi, M Hoshino, M Tagaya, et al.
Chirality|January 1, 1997
Stereoselective disposition and chiral inversion of KE-298, a new antirheumatic drug, in ratsH Yoshida, Y Kohno, H Endo, et al.
Uremia Investigation|January 1, 1984
A prospective study of urinary ligandin in patients at risk of renal tubular injuryR A Sherman, D A Feinfeld, N Ohmi, et al.
Biological & Pharmaceutical Bulletin|July 18, 2001
Stereoselectivity and species difference in plasma protein binding of KE-298 and its metabolitesH Endo, H Yoshida, M Hasegawa, et al.
Pageof 3